HomeCompareOMIC vs KMB

OMIC vs KMB: Dividend Comparison 2026

OMIC yields 10.00% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KMB wins by $7.2K in total portfolio value· pulled ahead in Year 8
10 years
OMIC
OMIC
● Live price
10.00%
Share price
$20.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38.7K
Annual income
$1,873.10
Full OMIC calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — OMIC vs KMB

📍 KMB pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOMICKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OMIC + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OMIC pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OMIC
Annual income on $10K today (after 15% tax)
$849.58/yr
After 10yr DRIP, annual income (after tax)
$1,592.14/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, KMB beats the other by $2,846.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OMIC + KMB for your $10,000?

OMIC: 50%KMB: 50%
100% KMB50/50100% OMIC
Portfolio after 10yr
$42.3K
Annual income
$3,547.72/yr
Blended yield
8.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

OMIC
Analyst Ratings
2
Buy
2
Hold
1
Sell
Consensus: Buy
Altman Z
-3.3
Piotroski
3/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OMIC buys
0
KMB buys
0
No recent congressional trades found for OMIC or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOMICKMB
Forward yield10.00%5.25%
Annual dividend / share$2.00$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$38.7K$45.9K
Annual income after 10y$1,873.10$5,222.34
Total dividends collected$14.3K$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: OMIC vs KMB ($10,000, DRIP)

YearOMIC PortfolioOMIC Income/yrKMB PortfolioKMB Income/yrGap
1$11,700$999.50$11,314$614.45+$386.00OMIC
2$13,611$1,092.86$12,867$760.19+$744.00OMIC
3$15,752$1,188.27$14,713$945.27+$1.0KOMIC
4$18,140$1,285.22$16,924$1,181.90+$1.2KOMIC
5$20,793$1,383.22$19,596$1,486.64+$1.2KOMIC
6$23,731$1,481.79$22,850$1,882.16+$881.00OMIC
7$26,972$1,580.48$26,849$2,399.80+$123.00OMIC
8← crossover$30,539$1,678.86$31,812$3,083.36$1.3KKMB
9$34,453$1,776.52$38,033$3,994.72$3.6KKMB
10$38,738$1,873.10$45,918$5,222.34$7.2KKMB

OMIC vs KMB: Complete Analysis 2026

OMICStock

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.

Full OMIC Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this OMIC vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OMIC vs SCHDOMIC vs JEPIOMIC vs OOMIC vs KOOMIC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.